Suppr超能文献

更健康的KL-VS杂合子具有更有利的与阿尔茨海默病相关的生物标志物特征。

More fit KL-VS heterozygotes have more favorable AD-relevant biomarker profiles.

作者信息

Jarchow Mackenzie, Driscoll Ira, Breidenbach Brianne M, Cook Noah, Gallagher Catherine L, Johnson Sterling C, Asthana Sanjay, Hermann Bruce P, Sager Mark A, Blennow Kaj, Zetterberg Henrik, Carlsson Cynthia M, Kollmorgen Gwendlyn, Quijano-Rubio Clara, Cook Dane B, Dubal Dena B, Okonkwo Ozioma C

机构信息

Wisconsin Alzheimer's Disease Research Center Department of Medicine School of Medicine and Public Health University of Wisconsin-Madison Madison Wisconsin USA.

Wisconsin Alzheimer's Institute Madison Wisconsin USA.

出版信息

Alzheimers Dement (N Y). 2025 Aug 8;11(3):e70133. doi: 10.1002/trc2.70133. eCollection 2025 Jul-Sep.

Abstract

INTRODUCTION

Although hallmarked by β-amyloid plaques (Aβ) and neurofibrillary tangles (tau), Alzheimer's disease (AD) is a multifactorial disorder that involves neuroinflammation, neurodegeneration, and synaptic dysfunction. AD-associated biomolecular changes seem to be attenuated in carriers of the functionally advantageous variant of the gene (KL-VS). Independently, better cardiorespiratory fitness (CRF) is associated with better health outcomes related to AD pathology. Here we investigate whether the relationships between CRF (peak oxygen consumption (VO)) and cerebrospinal fluid (CSF) core AD biomarkers and those of neuroinflammation, neurodegeneration, and synaptic dysfunction differ for KL-VS compared to noncarriers (KL-VS).

METHODS

The cohort, enriched for AD risk, consisted of cognitively unimpaired adults ( = 136; Mean(SD) = 62.5(6.7)) from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center. Covariate-adjusted (age, sex, parental AD history, apolipoprotein E ( 4+ status, and age difference between CSF sampling and exercise test) linear models examined the interaction between VO and genotype on CSF core AD biomarker levels (phosphorylated tau 181 [pTau], Aβ/Aβ, pTau/Aβ). Analyses were repeated for CSF biomarkers of neurodegeneration (total tau [tTau], α-synuclein [α-syn], neurofilament light polypeptide [NfL]), synaptic dysfunction (neurogranin [Ng]), and neuroinflammation (glial fibrillary acidic protein [GFAP], soluble triggering receptor expressed in myeloid cells [sTREM2], chitinase-3-like protein 1 [YKL-40], interleukin 6 [IL-6], S100 calcium-binding protein B [S100B]).

RESULTS

The interaction between VO and KL-VS was significant for tTau ( = 0.05), pTau ( = 0.03), Ng ( = 0.02), sTREM2 ( = 0.03), and YKL-40 ( = 0.03), such that lower levels of each biomarker were observed for KL-VS who were more fit. No significant KL-VSxVO interactions were observed for Aβ/Aβ, pTau/Aβ, α-syn, NfL, GFAP, IL-6 or S100B (all s>0.09).

CONCLUSIONS

We report a synergistic relationship between KL-VS and CRF with pTau, tTau, Ng, sTREM2 and YKL-40, suggesting a protective role for both KL-VS and better CRF against unfavorable AD-related changes. Their potentially shared biological mechanisms require future investigations.

HIGHLIGHTS

KL-VS and higher cardiorespiratory fitness (CRF) may protect against unfavorable Alzheimer's disease (AD)-related changes.Higher CRF attenuates neurodegeneration and synaptic dysfunction in KL-VS.More fit KL-VS also has lower levels of pTau and less neuroinflammation.

摘要

引言

尽管阿尔茨海默病(AD)以β-淀粉样蛋白斑块(Aβ)和神经原纤维缠结(tau)为特征,但它是一种多因素疾病,涉及神经炎症、神经退行性变和突触功能障碍。AD相关的生物分子变化在基因(KL-VS)功能优势变体的携带者中似乎有所减弱。另外,更好的心肺适能(CRF)与AD病理学相关的更好健康结果有关。在此,我们研究与非携带者(KL-VS)相比,KL-VS的CRF(峰值耗氧量(VO))与脑脊液(CSF)核心AD生物标志物之间以及神经炎症、神经退行性变和突触功能障碍之间的关系是否存在差异。

方法

该队列富含AD风险因素,由来自威斯康星州阿尔茨海默病预防登记处和威斯康星州阿尔茨海默病研究中心的认知未受损成年人(n = 136;平均(标准差)= 62.5(6.7))组成。经协变量调整(年龄、性别、父母AD病史、载脂蛋白E(ε4+状态以及CSF采样与运动测试之间的年龄差异)的线性模型检验了VO与基因型对CSF核心AD生物标志物水平(磷酸化tau 181 [pTau]、Aβ42/Aβ40、pTau/Aβ42)的相互作用。对神经退行性变(总tau [tTau]、α-突触核蛋白[α-syn]、神经丝轻链多肽[NfL])、突触功能障碍(神经颗粒素[Ng])和神经炎症(胶质纤维酸性蛋白[GFAP]、髓样细胞中表达的可溶性触发受体[sTREM2]、几丁质酶-3样蛋白1 [YKL-40]、白细胞介素6 [IL-6]、S100钙结合蛋白B [S100B])的CSF生物标志物重复进行分析。

结果

VO与KL-VS之间的相互作用在tTau(p = 0.05)、pTau(p = 0.03)、Ng(p = 0.02)、sTREM2(p = 0.03)和YKL-40(p = 0.03)方面具有显著性,因此对于身体更健康的KL-VS携带者,观察到每种生物标志物的水平较低。在Aβ42/Aβ40、pTau/Aβ42、α-syn、NfL、GFAP、IL-6或S100B方面未观察到显著的KL-VS×VO相互作用(所有p>0.09)。

结论

我们报告了KL-VS与CRF在pTau、tTau、Ng、sTREM2和YKL-40方面存在协同关系,表明KL-VS和更好的CRF对不利的AD相关变化均具有保护作用。它们潜在的共同生物学机制需要未来进一步研究。

要点

KL-VS和更高的心肺适能(CRF)可能预防不利的阿尔茨海默病(AD)相关变化。更高的CRF可减轻KL-VS中的神经退行性变和突触功能障碍。身体更健康的KL-VS携带者的pTau水平也较低且神经炎症较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7c/12333875/a8c7c3ad3f6a/TRC2-11-e70133-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验